Takuma Shikata

743 total citations
10 papers, 620 citations indexed

About

Takuma Shikata is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Takuma Shikata has authored 10 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Immunology. Recurrent topics in Takuma Shikata's work include Neuroblastoma Research and Treatments (5 papers), Cancer therapeutics and mechanisms (3 papers) and Signaling Pathways in Disease (2 papers). Takuma Shikata is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Cancer therapeutics and mechanisms (3 papers) and Signaling Pathways in Disease (2 papers). Takuma Shikata collaborates with scholars based in Japan and United States. Takuma Shikata's co-authors include Hajime Hosoi, Michael B. Dilling, Peter J. Houghton, Robert T. Abraham, Lili Shu, Glen S. Germain, Richard A. Ashmun, Peter J. Houghton, Shile Huang and Mary K. Danks and has published in prestigious journals such as Molecular Pharmacology, Acta Paediatrica and Child s Nervous System.

In The Last Decade

Takuma Shikata

10 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takuma Shikata Japan	8	457	154	85	66	66	10	620
Gaia Roversi Italy	13	592 1.3×	131 0.9×	121 1.4×	53 0.8×	139 2.1×	18	960
J.M. Trent United States	11	282 0.6×	168 1.1×	104 1.2×	62 0.9×	76 1.2×	20	563
Zamir Brelvi United States	8	298 0.7×	121 0.8×	39 0.5×	79 1.2×	34 0.5×	21	490
Rama Jasty United States	11	372 0.8×	141 0.9×	82 1.0×	39 0.6×	46 0.7×	18	583
Hashmat Sikder United States	6	366 0.8×	135 0.9×	125 1.5×	35 0.5×	35 0.5×	6	515
Hilda Martinez-Diaz United States	4	621 1.4×	253 1.6×	138 1.6×	65 1.0×	75 1.1×	4	755
Hauke Sieverts Germany	8	506 1.1×	214 1.4×	121 1.4×	75 1.1×	29 0.4×	13	749
Amanda J. Russell Australia	16	571 1.2×	238 1.5×	129 1.5×	39 0.6×	49 0.7×	27	789
Brenden Chen United States	12	878 1.9×	169 1.1×	73 0.9×	46 0.7×	90 1.4×	20	1.1k
John M. Krill-Burger United States	11	504 1.1×	88 0.6×	118 1.4×	22 0.3×	61 0.9×	14	679

Countries citing papers authored by Takuma Shikata

Since Specialization

Citations

This map shows the geographic impact of Takuma Shikata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuma Shikata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuma Shikata more than expected).

Fields of papers citing papers by Takuma Shikata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuma Shikata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuma Shikata. The network helps show where Takuma Shikata may publish in the future.

Co-authorship network of co-authors of Takuma Shikata

This figure shows the co-authorship network connecting the top 25 collaborators of Takuma Shikata. A scholar is included among the top collaborators of Takuma Shikata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuma Shikata. Takuma Shikata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Huang, Shile, et al.. (2001). p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.. PubMed. 61(8). 3373–81. 110 indexed citations

Matsumura, Takafumi, Takuma Shikata, Johji Inazawa, et al.. (2000). Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line.. PubMed. 19(5B). 4049–57. 14 indexed citations

Misawa, Akiko, Hajime Hosoi, Takuma Shikata, et al.. (2000). N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells.. PubMed. 60(1). 64–9. 38 indexed citations

Shikata, Takuma, et al.. (2000). Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up‐regulation by interferon‐γ. Medical and Pediatric Oncology. 34(6). 394–401. 1 indexed citations

Shikata, Takuma, et al.. (2000). Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-?. Medical and Pediatric Oncology. 34(6). 394–401. 12 indexed citations

Hosoi, Hajime, Michael B. Dilling, Takuma Shikata, et al.. (1999). Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.. PubMed. 59(4). 886–94. 257 indexed citations

Yoshida, Mariko, Shinji Fushiki, Yoshihiro Takeuchi, et al.. (1998). Diffuse bilateral thalamic astrocytomas as examined serially by MRI. Child s Nervous System. 14(8). 384–388. 15 indexed citations

Hosoi, Hajime, Michael B. Dilling, Mary K. Danks, et al.. (1998). Studies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells. Molecular Pharmacology. 54(5). 815–824. 157 indexed citations

Sugimoto, Tohru, et al.. (1994). Increased Expression of trk Proto‐oncogene by γ‐Interferon in Human Neuroblastoma Cell Lines. Japanese Journal of Cancer Research. 85(2). 122–126. 9 indexed citations

10.

Yoshida, Naoko, Takuma Shikata, Atsuko Matsumura, et al.. (1991). Alloimmune Neonatal Neutropenia in Monozygous Twins: High‐dose Intravenous Gammaglobulin Therapy. Acta Paediatrica. 80(1). 62–65. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact